ModelEdge
20/20 GeneSystems, Inc.
0001139685
Filing type
1-U
Filing date
Nov 20, 2025
Updated
Nov 21, 2025 ยท 1:16 PM

Filing

1-UCurrent Report for Regulation A

Exhibits

EX1U-3 HLDRS RTSWARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON NOVEMBER 17, 2025EX1U-6 MAT CTRCTSECURITIES PURCHASE AGREEMENT, DATED NOVEMBER 17, 2025, BETWEEN 20/20 BIOLABS, INC. AND STREETERVILLE CAPITAL, LLCEX1U-6 MAT CTRCTSECURED CONVERTIBLE PROMISSORY NOTE ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON NOVEMBER 17, 2025EX1U-6 MAT CTRCTSECURITY AGREEMENT, DATED NOVEMBER 17, 2025, BETWEEN 20/20 BIOLABS, INC. AND STREETERVILLE CAPITAL, LLCEX1U-6 MAT CTRCTINTELLECTUAL PROPERTY SECURITY AGREEMENT, DATED NOVEMBER 17, 2025, BETWEEN 20/20 BIOLABS, INC. AND STREETERVILLE CAPITAL, LLCEX1U-6 MAT CTRCTSECURITIES PURCHASE AGREEMENT, DATED NOVEMBER 17, 2025, BETWEEN 20/20 BIOLABS, INC. AND STREETERVILLE CAPITAL, LLCEX1U-6 MAT CTRCTPLACEMENT AGENCY AGREEMENT, DATED NOVEMBER 18, 2025, BETWEEN 20/20 BIOLABS, INC. AND MAXIM GROUP LLC